Form 8-K - Current report:
SEC Accession No. 0001493152-21-021171
Filing Date
2021-08-25
Accepted
2021-08-25 06:35:17
Documents
31
Period of Report
2021-08-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36751
2 ex99-1.htm EX-99.1 36472
3 logo_001.jpg GRAPHIC 5687
4 ex99-2.htm EX-99.2 21141
5 ex99-2_001.jpg GRAPHIC 78293
6 ex99-2_002.jpg GRAPHIC 255590
7 ex99-2_003.jpg GRAPHIC 121560
8 ex99-2_004.jpg GRAPHIC 157758
9 ex99-2_005.jpg GRAPHIC 168951
10 ex99-2_006.jpg GRAPHIC 97532
11 ex99-2_007.jpg GRAPHIC 90389
12 ex99-2_008.jpg GRAPHIC 110191
13 ex99-2_009.jpg GRAPHIC 101811
14 ex99-2_010.jpg GRAPHIC 102995
15 ex99-2_011.jpg GRAPHIC 126902
16 ex99-2_012.jpg GRAPHIC 142392
17 ex99-2_013.jpg GRAPHIC 120180
18 ex99-2_014.jpg GRAPHIC 99353
19 ex99-2_015.jpg GRAPHIC 157920
20 ex99-2_016.jpg GRAPHIC 121635
  Complete submission text file 0001493152-21-021171.txt   3122408

Data Files

Seq Description Document Type Size
21 XBRL SCHEMA FILE lpcn-20210825.xsd EX-101.SCH 3024
22 XBRL LABEL FILE lpcn-20210825_lab.xml EX-101.LAB 34239
23 XBRL PRESENTATION FILE lpcn-20210825_pre.xml EX-101.PRE 22358
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3605
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 211203574
SIC: 2834 Pharmaceutical Preparations